| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
08-26-2010, 02:41 PM
|
#1 | ||
|
|||
|
Magnate
|
The governing board of California Institute for Regenerative Medicine (Palo Alto, CA), the state stem-cell agency, approved the concept for up to $243 million round of funding to move stem cell-based therapies to clinical trial. The funding will support multidisciplinary teams of researchers working toward filing a request with the US Food and Drug Administration to begin clinical trials, or completing an early stage trial, within four years.
|
||
|
 Reply With Quote
|
|
08-26-2010, 03:02 PM
|
#2 | |||
|
||||
|
Senior Member
|
Our old friend, PAN Founder Joan Samuelson, represents Parkinson's Disease on the CIRM. Since they don't take federal funds, they are not bound by the recent court decision that has recently halted other embryonic stem cell research. Lucky for us that California is independent and ahead of the curve in this area of research.
__________________
Carey “Cautious, careful people, always casting about to preserve their reputation and social standing, never can bring about a reform. Those who are really in earnest must be willing to be anything or nothing in the world’s estimation, and publicly and privately, in season and out, avow their sympathy with despised and persecuted ideas and their advocates, and bear the consequences.” — Susan B. Anthony |
|||
|
|
Reply With Quote
|
| "Thanks for this!" says: | soccertese (08-26-2010) |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| ALS Therapy Development Institute and California Stem Cell, Inc. Announce Long-Term S | ALS News & Research | |||
| Institute of Women's Health & Integrative Medicine | Women's Health | |||
The governing board of California Institute for Regenerative Medicine (Palo Alto, CA
Linear Mode
